Study on Cytochrome P450 Family 1 B1 Gene Mutations in Primary Congenital Glaucoma Affected Egyptian Patients

Author(s):  
Amanne Feisal Esmael ◽  
Hanaa Abdel-Sadek Oraby ◽  
Soheir Mohamed El Nahas
Author(s):  
Amanne Feisal Esmael ◽  
Hanaa Abdel-Sadek Oraby ◽  
Soheir Mohamed El Nahas

Aims: Primary congenital glaucoma (PCG) is a leading cause of childhood blindness. The cytochrome P450 family 1, subfamily B, polypeptide 1 (CYP1B1) is the most mutated gene that is associated with PCG. Very few studies have examined the promoter region and exon1 of the CYP1B1 gene. This work was planned to contribute to the description of the possible causative mutations of CYP1B1 gene that are related to PCG affected Egyptian patients. Patients and Methods: Patients diagnosed as glaucomatous based on their symptoms and detailed ophthalmological examinations at the time of presentation underwent an intraocular pressure lowering surgical procedure. Investigations were further proceeded on the molecular level. Sequencing-based mutation screen for the promoter region, exon1 and the coding region of exon3 of CYP1B1 gene have been performed in two related consanguineous PCG affected families and four other sporadic Egyptian patients using the polymerase chain reaction (PCR) assay; where PCR products were sequenced, and further analyzed. Results: Sequencing analysis revealed three novel mutations in PCG affected patients one in the promoter region (g.G2872A) and two in exon1 (g.C3268T and g.C3332T). Two additional mutations in exon3 (p.L432V and p.N453S) reported for the first time in PCG affected Egyptian patients. Clinical and genetic data of the two consanguineous families revealed that although the four parents have the same variations as their sons, they are ophthalmologically free. Conclusion: Regular ophthalmic examinations of siblings and parents of these affected patients should take place for early detection of any form of glaucoma to allow prompt diagnosis and early treatment when needed. Clinical examination and molecular genetic data could contribute to early diagnosis and prevention of the visual impairment caused by PCG. This study provides groundwork for expanded genetic investigations in Egypt paving the way for genetic counseling to help affected families make informed medical and personal decisions.


2011 ◽  
Vol 93 (5) ◽  
pp. 572-579 ◽  
Author(s):  
Ni Li ◽  
Yong Zhou ◽  
Liang Du ◽  
Maoling Wei ◽  
Xiaoming Chen

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Noha S Mohammad ◽  
Saad M Rashad ◽  
Tarek A el Maamoun ◽  
Osama K Zaki ◽  
Thanaa H Mohamed ◽  
...  

Abstract Background Primary congenital glaucoma (PCG) is a leading cause of childhood blindness in Egypt. The discovery of the underlying genetic causes has led to far greater understanding of disease mechanisms. Cytochrome P450, family 1, subfamily B, polypeptide 1(CYP1B1) gene mutations usually inherited in an autosomal recessive manner are one of the major etiologies behind PCG. Gene screening aids early diagnosis of PCG which is a key factor in managing and preventing blindness from the disease. Aim This study aims to screen for CYP1B1gene mutations in PCG patients and study its possible impact on surgical outcome of PCG. Methods Twenty-four PCG patients enrolled in this study underwent trabeculotomy, and were followed up at a 3 month interval for a year. Patients’ demographic details were recorded, and their genomic DNA was screened for CYP1B1 mutations. Genotypic impact on surgical outcome was compared between the group of patients who harbored mutations and the group unsolved with mutations. Results Six different disease causing CYP1B1 mutations were identified in 13 (54.17 %) of affected patients who exhibited more surgical failure at the last follow up visit. Conclusion This study further endorses CYP1B1 mutations as a possible etiological and prognostic factor for PCG.


2017 ◽  
Vol 18 (3) ◽  
pp. 219-224 ◽  
Author(s):  
Mahmoud R. Fassad ◽  
Asmaa K. Amin ◽  
Heba A. Morsy ◽  
Noha M. Issa ◽  
Nader H. Bayoumi ◽  
...  

2015 ◽  
Vol 24 (8) ◽  
pp. 630-634 ◽  
Author(s):  
Laura Morales-Fernandez ◽  
Jose M. Martinez-de-la-Casa ◽  
Javier Garcia-Bella ◽  
Carmen Mendez ◽  
Federico Saenz-Frances ◽  
...  

2018 ◽  
Vol 27 (3) ◽  
pp. 1-10
Author(s):  
Roseline Duke ◽  
Mary E. Kooffreh ◽  
Anthony John Umoyen ◽  
Ekerette Emmanuel Ekerette ◽  
Owoidihe Monday Etukudo ◽  
...  

2017 ◽  
Vol 06 (04) ◽  
pp. 205-214 ◽  
Author(s):  
Leila Chouiter ◽  
Sellama Nadifi

AbstractPrimary congenital glaucoma (PCG) is the most common type of infantile glaucoma, yet it remains a relatively rare disease, because the disease is often transmitted in an autosomal recessive pattern. However, PCG occurs up to 10 times more frequently in certain ethnic and geographical groups where consanguineous relationships are common. The aim of this study was to investigate the distribution of mutations in the cytochrome P450 1B1 gene (CYP1B1) in patients with PCG among different populations around the world from 2011 until May 2016. We referred to the electronic databases, such as Medline, Clinicalkey, Scopus, and ScienceDirect, to search for articles that were published in this area. Nineteen records were included in this qualitative synthesis. CYP1B1 mutations were assessed in 1,220 patients with PCG and identified in 41.6% of them. According to these studies, 99 mutations including 60 novel mutations were found. Nonsignificant difference in the sex ratio has been reported. This current review shows that consanguinity plays an important role in the PCG pathogenesis and transmission; however, sporadic mutations have been found in some cases. A difference in penetrance was highlighted by some mutations. The CYP1B1 mutations were mostly found in the Middle East and the Maghreb with a rate of 64.8 and 54.4%, respectively, followed by Europe (34.7%), Asia (21.3%), and finally the United States (14.9%). Founder mutations in different geographical areas have been discovered. For instance, the p.Gly61Glu, p.Arg390His, p.Gly61Glu, c.4,339delG, p.E387Lys, and p.Val320Leu were considered founder mutations for Iran/Saudi Arabia, Pakistan, Lebanon, Morocco, Europe, and Vietnam/South Korea, respectively. Many common mutations in different countries were found, such as in Morocco, where its mutations were similar to seven other countries. These findings suggest that the ethnic differences and the geographical distribution of PCG give us a large CYP1B1 mutation pattern. Genetic tests looking for founder and common mutations should be the first step in genetic screening for patients with PCG.


2015 ◽  
Vol 10 (1) ◽  
pp. 60 ◽  
Author(s):  
Nader Sheibani ◽  
Yun Zhao ◽  
ChristineM Sorenson

2010 ◽  
Vol 19 (6) ◽  
pp. 398-404 ◽  
Author(s):  
Mukesh Tanwar ◽  
Ramanjit Sihota ◽  
Tanuj Dada ◽  
Vinay Gupta ◽  
Taposh K. Das ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document